Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model

Objective: Telmisartan is an angiotensin receptor blocker (ARB) that specifically blocks angiotensin II type-1 receptors (AT1R). Telmisartan has been proven to have antidiabetic effects via a variety of mechanisms, and it can be utilized in some diabetic patients due to its dual benefit for hyperten...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd-Eltawab Tammam, Ahmed, Rizg, Waleed Y., Fakhry Boushra, Amy, Alhelf, Maha, Alissa, Mohammed, Soliman, Ghada F., Nady Ouais, Ghada, Hosny, Khaled M., Alkhalidi, Hala M., Elebiary, Ahmed Magdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416801/
https://www.ncbi.nlm.nih.gov/pubmed/37576807
http://dx.doi.org/10.3389/fphar.2023.1228525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416801/
https://www.ncbi.nlm.nih.gov/pubmed/37576807
http://dx.doi.org/10.3389/fphar.2023.1228525

Ejemplares similares